These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3747602)

  • 21. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.
    Duan R; Remeijer L; van Dun JM; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):277-84. PubMed ID: 17197544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K; Barth RF; Wilkie N; Lang JC; Oda Y; Kikuchi H; Everson MP; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):113-24. PubMed ID: 7621259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cells induce apoptosis via a novel mechanism in fibroblasts infected with mouse hepatitis virus.
    Nishioka WK; Welsh RM
    Nat Immun; 1993; 12(3):113-27. PubMed ID: 8392406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An anti-human recombinant tumor necrosis factor alpha (TNF alpha) monoclonal antibody recognizes an epitope in feline TNF alpha.
    Aguirre A; Escobar A; Ferreira V; Molina MC; Ferreira A; Aguillón JC
    Vet Res; 2003; 34(2):177-84. PubMed ID: 12657209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.
    Carter VC; Schaffer PA; Tevethia SS
    J Immunol; 1981 May; 126(5):1655-60. PubMed ID: 6971309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
    Wright P; Zheng C; Moyana T; Xiang J
    Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells.
    Lachman LB; Dinarello CA; Llansa ND; Fidler IJ
    J Immunol; 1986 Apr; 136(8):3098-102. PubMed ID: 3485680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.
    Taverne J; Tavernier J; Fiers W; Playfair JH
    Clin Exp Immunol; 1987 Jan; 67(1):1-4. PubMed ID: 3621669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute in vivo effects of human recombinant tumor necrosis factor.
    Remick DG; Kunkel RG; Larrick JW; Kunkel SL
    Lab Invest; 1987 Jun; 56(6):583-90. PubMed ID: 3599906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1.
    Schmitt DA; Sasaki H; Pollard RB; Suzuki F
    Antiviral Res; 1992 Oct; 19(4):347-52. PubMed ID: 1463323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and characterization of monoclonal antibodies against recombinant human tumor necrosis factor/cachectin.
    Liang CM; Liang SM; Jost T; Sand A; Dougas I; Allet B
    Biochem Biophys Res Commun; 1986 Jun; 137(2):847-54. PubMed ID: 3729942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.
    Flick DA; Gifford GE
    J Immunol Methods; 1984 Mar; 68(1-2):167-75. PubMed ID: 6707477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin.
    Averbook BJ; Yamamoto RS; Ulich TR; Jeffes EW; Masunaka I; Granger GA
    J Clin Immunol; 1987 Jul; 7(4):333-40. PubMed ID: 3611300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on tumor necrosis factor (TNF)].
    Haranaka K; Satomi N; Sakurai A; Kunii O
    Nihon Rinsho; 1982; 40(8):1872-9. PubMed ID: 6755003
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluorescence-based microplate bioassay for tumor necrosis factor.
    Imrich A; Taylor M; Kobzik L
    J Immunol Methods; 1998 Mar; 212(1):109-12. PubMed ID: 9671159
    [No Abstract]   [Full Text] [Related]  

  • 37. Assays for cytotoxicity.
    Meager A
    Methods Mol Biol; 2004; 249():135-52. PubMed ID: 14573897
    [No Abstract]   [Full Text] [Related]  

  • 38. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.
    Yamazaki S; Onishi E; Enami K; Natori K; Kohase M; Sakamoto H; Tanouchi M; Hayashi H
    Jpn J Med Sci Biol; 1986 Jun; 39(3):105-18. PubMed ID: 3784109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Physiological Role of Tumor Necrosis Factor in Human Immunity and Its Potential Implications in Spinal Manipulative Therapy: A Narrative Literature Review.
    Zhang L; Yao CH
    J Chiropr Med; 2016 Sep; 15(3):190-6. PubMed ID: 27660595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.
    Klimstra WB; Ryman KD; Bernard KA; Nguyen KB; Biron CA; Johnston RE
    J Virol; 1999 Dec; 73(12):10387-98. PubMed ID: 10559357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.